The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis
- PMID: 20042073
- PMCID: PMC2811704
- DOI: 10.1186/1742-2094-6-42
The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis
Abstract
Background: The chemokine CXCL13 is known to dictate homing and motility of B cells in lymphoid tissue and has been implicated in the formation of ectopic lymphoid tissue in chronic inflammation. Whether it influences B cell trafficking during acute infection, is largely unclear. In previous studies, we showed that (I) CXCL13 levels are markedly increased in the B cell-rich cerebrospinal fluid (CSF) of patients with acute Lyme neuroborreliosis (LNB), and (II) CXCL13 is released by monocytes upon recognition of borrelial outer surface proteins by Toll-like receptor 2. Here, we assessed the role of CXCL13--in comparison to other chemokines--in the recruitment of B cells to the CSF of patients with acute LNB.
Methods: Measurement of chemokines was done by ELISA. B cells were isolated from whole blood using magnetic cell separation (MACS). For migration experiments, a modified Boyden chamber assay was used and the migrated B cells were further analysed by FACS. The migration was inhibited either by preincubation of the CSF samples with neutralizing antibodies, heating to 60 degrees C, removal of proteins >3 kDa, or by pre-treatment of the B cells with pertussis toxin. The principal statistical tests used were one-way analysis of variance and Bonferroni test (chemokine measurements) as well as paired Student's t-test (migration experiments).
Results: Measurements of chemokine levels revealed an increase in three of the four known major B cell chemoattractants CXCL13, CCL19 and CXCL12 in LNB CSF. The CXCL13 CSF:serum ratio, as a measure of the chemotactic gradient, was substantially higher than that of CCL19 and CXCL12. Moreover, the chemotactic activity of LNB CSF was reduced up to 56% after preincubation with a neutralizing CXCL13 antibody, while combined preincubation with antibodies against CXCL13, CCL19, and CXCL12 did not lead to further reduction. Since treatment with pertussis toxin, heating to 60 degrees C, and removal of proteins >3 kDa abrogated the chemotactic activity, further not yet identified chemokines seem to be involved in B cell recruitment to LNB CSF.
Conclusion: Combined, our study suggests a key role of CXCL13 in B cell migration to sites of infection as shown here for the CSF of LNB patients.
Figures





Similar articles
-
CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.J Neurol. 2008 May;255(5):732-7. doi: 10.1007/s00415-008-0785-y. Epub 2008 Mar 17. J Neurol. 2008. PMID: 18344056
-
CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.J Neuroinflammation. 2014 Jun 11;11:103. doi: 10.1186/1742-2094-11-103. J Neuroinflammation. 2014. PMID: 24920219 Free PMC article.
-
The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.Infect Dis (Lond). 2019 Nov-Dec;51(11-12):856-863. doi: 10.1080/23744235.2019.1671988. Epub 2019 Oct 1. Infect Dis (Lond). 2019. PMID: 31573360
-
Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.Int J Mol Sci. 2020 Apr 22;21(8):2927. doi: 10.3390/ijms21082927. Int J Mol Sci. 2020. PMID: 32331231 Free PMC article. Review.
-
Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.Clin Microbiol Infect. 2018 Dec;24(12):1234-1240. doi: 10.1016/j.cmi.2018.04.007. Epub 2018 Apr 16. Clin Microbiol Infect. 2018. PMID: 29674128
Cited by
-
Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.PLoS One. 2012;7(11):e48370. doi: 10.1371/journal.pone.0048370. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226202 Free PMC article.
-
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep. Clin Vaccine Immunol. 2016. PMID: 27358211 Free PMC article.
-
CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.BMC Infect Dis. 2012 Dec 10;12:344. doi: 10.1186/1471-2334-12-344. BMC Infect Dis. 2012. PMID: 23228054 Free PMC article.
-
A new chemotaxis device for cell migration studies.Integr Biol (Camb). 2010 Nov;2(11-12):696-706. doi: 10.1039/c0ib00044b. Epub 2010 Oct 12. Integr Biol (Camb). 2010. PMID: 20938544 Free PMC article.
-
B cell dysregulation in primary Sjögren's syndrome: A review.Jpn Dent Sci Rev. 2019 Nov;55(1):139-144. doi: 10.1016/j.jdsr.2019.09.006. Epub 2019 Oct 21. Jpn Dent Sci Rev. 2019. PMID: 31687053 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous